Prevalence of hepatitis C virus antibody [1]

Annals of Saudi Medicine

Volumn 20, Issue 5-6, 2000, Pages 488-489

  Al Hawsawi, Z M ^a  

^a King Salman Bin Abdulaziz Medical City   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; HEPATITIS C ANTIBODY; HEPATITIS C VACCINE;

ADOLESCENT; ADULT; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CHILD; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HIGH RISK PATIENT; HUMAN; IMMUNOBLOTTING; INFECTION RISK; LETTER; LIVER CIRRHOSIS; LIVER INJURY; MALE; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; SAUDI ARABIA; SEROPREVALENCE; SICKLE CELL ANEMIA; THALASSEMIA;

EID: 0034431857     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.2000.488     Document Type: Letter

References (16)

1. A short guide to the management of thalassemia
2. An assay for circulating antibodies to a major etiologic virus of human non A non B hepatitis
3. Hepatitis C virus: The major causative agent of viral non A non B hepatitis
4. Antibody to hepatitis C virus in post-transfusion hepatitis
5. Hepatitis C virus antibodies in high-risk Saudi groups
6. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma
7. Incidence and frequency of hemoglobinopathies and thalassemia in the northwest sector of Saudi Arabia
8. Prevalence of hepatitis B, hepatitis C and human immune deficiency virus markers among patients with hereditary haemolytic anaemias
9. Beta-thalassemia major in Kuwait
10. Decline in hepatitis B infection in sickle cell anemia and beta-thalassemia major
11. Hepatitis C virus infection and liver disease in children with thalassemia
12. Hepatitis E virus infection in patients from Saudi Arabia with sickle cell anemia and beta-thalassemia major. Possible transmission by blood transfusion
13. Prevalence and significance of antibodies to hepatitis C virus among Saudi hemodialysis patients
14. Surrogate markers are not useful for identification of HCV carriers in chronic haemodialysis patients
15. Long-term efficacy of alpha-interferon in beta thalassemics with chronic hepatitis C
16. High-dosage alpha interferon for treatment of children and young adults with chronic hepatitis C disease